COMPARABILITY OF HBA1C AND LIPIDS MEASURED WITH DRIED BLOOD SPOT VERSUS VENOUS SAMPLES: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v9i1.1522Keywords:
Dried Blood Spot, HbA1c, Lipids, VenousAbstract
Diabetes is a major risk factor for cardiovascular disease, which is spreading at an alarming rate over the world, but it is especially widespread in developing nations. The infrastructure and resources required to conduct research are frequently insufficient in these countries, making it difficult to establish the role that dysglycemia and other metabolic risk factors play. DBS samples are now routinely used to evaluate serum antibodies, human immunodeficiency virus (HIV) loads, and blood hormone levels. There is enough evidence to prove the comparability of results between research using DBS samples and those using conventional venous samples. The DBS method appears to hold significant potential for addressing the logistical challenges of venous sampling for research of metabolic risks in resource-constrained situations, but only if standards and calibrations can be agreed upon, as has been done in other fields of study. As a result of the breadth of comparisons provided by our findings, we may conclude that these generalizations are true of data acquired from a variety of different laboratories. There have been reports in the scientific literature concerning findings that are equivalent in terms of the strength of the linkages between DBS assay values and venous sample values. Tests based on DBS samples are clearly related with assays based on standard venous samples for HbA1c and selected blood lipids.
References
Zipes D, Libby P, Bonow R. Braunwald’s Heart Disease. 8th ed. Philadelphia: Elsevier; 2019.
Ponikowski P; Voors AA; Anker SD; et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(27):2129–200.
Cagle SD, Cooperstein N. Coronary Artery Disease: Diagnosis and Management. Prim Care. 2018;45(1):45–61.
Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016 Jan;37(1):67–119.
Lind L, Ingelsson M, Sundstrom J, Ärnlöv J. Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings. Open Hear. 2021 Sep;8(2).
Brown AE, Walker M. Genetics of Insulin Resistance and the Metabolic Syndrome. Curr Cardiol Rep. 2016 Aug;18(8):75.
Jones TG, Warber KD, Roberts BD. Analysis of hemoglobin A1c from dried blood spot samples with the Tina-quantR II immunoturbidimetric method. J Diabetes Sci Technol. 2010 Mar;4(2):244–9.
Mei J V, Alexander JR, Adam BW, Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr. 2001;131(5):1631S-1636S.
Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther. 2009;14(5):619–29.
McDade TW, Williams S, Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography. 2007;44(4):899–925.
Crimmins E, Kim JK, McCreath H, Faul J, Weir D, Seeman T. Validation of blood-based assays using dried blood spots for use in large population studies. Biodemography Soc Biol. 2014;60(1):38–48.
Mastronardi CA, Whittle B, Tunningley R, Neeman T, Paz-Filho G. The use of dried blood spot sampling for the measurement of HbA1c: a cross-sectional study. BMC Clin Pathol. 2015;15(1):1–7.
Börsch?Supan A, Weiss LM, Börsch?Supan M, Potter AJ, Cofferen J, Kerschner E. Dried blood spot collection, sample quality, and fieldwork conditions: Structural validations for conversion into standard values. Am J Hum Biol. 2021;33(4):e23517.
Fauci AS, Jameson JL, Kasper D, et al. Harrison’s Principles of Internal Medicine 19th Edition. New York: McGraw-Hill Education; 2018.
Price SA; Lorraine MW, Price SA LM, Price SA; Lorraine MW, Price SA LM. Patofisiologi Konsep Klinis Proses-Proses Penyakit. Jakarta: EGC; 2016.
Williams SR, McDade TW. The use of dried blood spot sampling in the national social life, health, and aging project. Journals Gerontol Ser B Psychol Sci Soc Sci. 2009;64(suppl_1):i131–6.
McDade TW. Development and validation of assay protocols for use with dried blood spot samples. Am J Hum Biol. 2014;26(1):1–9.
McDade TW, Burhop J, Dohnal J. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin Chem. 2004;50(3):652–4.
Fokkema MR, Bakker AJ, de Boer F, Kooistra J, de Vries S, Wolthuis A. HbA1c measurements from dried blood spots: validation and patient satisfaction. Clin Chem Lab Med. 2009;47(10):1259–64.
Selvin E, Coresh J, Jordahl J, Boland L, Steffes MW. Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade. Diabet Med. 2005;22(12):1726–30.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advance Research in Medical & Health Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
